Basic Information
| LncRNA/CircRNA Name | circ_100338 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR, RIP |
| Sample | liver cancer cell lines |
| Expression Pattern | down-regulated |
| Function Description | The expression characteristics of circ-100338 in HCC cell lines were also verified by qRT-PCR. Moreover high expression of circ-100338 can stimulate the proliferation of HCC cells. |
| Pubmed ID | 32281302 |
| Year | 2020 |
| Title | Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression |
External Links
| Links for circ_100338 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |